Bluesky Explorer

#SIM0278

Latest posts tagged with #SIM0278 on Bluesky

Trending

#World Baseball Classic #Rachel Maddow #Trump and Cuba #Vaccine Policy #DLSS 5 #Oscars #Strait of Hormuz #Sonic Racing #Ukraine Conflict #World Baseball Classic #Rachel Maddow #Trump and Cuba #Vaccine Policy #DLSS 5 #Oscars #Strait of Hormuz #Sonic Racing #Ukraine Conflict

Posts tagged #SIM0278

Thiard News@F4F

@newsen.bsky.social

4 months ago

Preview

Simcere's Mutant IL-2 Fusion Protein SIM0278 Enters Phase II Clinical Trials Simcere Pharmaceutical Group announces the advancement of SIM0278, a mutant IL-2 fusion protein, into Phase II clinical trials targeting moderate to severe atopic dermatitis.

Simcere's Mutant IL-2 Fusion Protein SIM0278 Enters Phase II Clinical Trials #China #Hangzhou #Atopic_Dermatitis #Simcere #SIM0278

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

4 months ago

Preview

Simcere's Breakthrough IL-2 Mutant Protein SIM0278 Advances to Phase II Trials Simcere Pharmaceutical Group has announced that its mutant IL-2 fusion protein, SIM0278, has entered Phase II clinical trials for the treatment of moderate to severe atopic dermatitis.

Simcere's Breakthrough IL-2 Mutant Protein SIM0278 Advances to Phase II Trials #China #Hangzhou #Atopic_Dermatitis #Simcere #SIM0278

1 0 0 0

Thiard News@F4F

@newsen.bsky.social

4 months ago

Preview

Simcere Launches Phase II Clinical Trials for SIM0278, a Mutant IL-2 Fusion Protein Simcere Pharmaceutical has begun Phase II trials of SIM0278, a mutant IL-2 protein aimed at treating moderate to severe atopic dermatitis. This significant step seeks to enhance patient care globally.

Simcere Launches Phase II Clinical Trials for SIM0278, a Mutant IL-2 Fusion Protein #China #Nanjing #Simcere #SIM0278 #IL-2

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

4 months ago

Preview

Simcere's Innovative IL-2 Mutant Fusion Protein Enters Phase II Trials to Combat Atopic Dermatitis Simcere Pharmaceutical’s IL-2 mu-Fc, SIM0278, has entered Phase II clinical trials in China for treating moderate-to-severe atopic dermatitis, offering new hope to patients.

Simcere's Innovative IL-2 Mutant Fusion Protein Enters Phase II Trials to Combat Atopic Dermatitis #China #Hangzhou #Atopic_Dermatitis #Simcere #SIM0278

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

4 months ago

Preview

Simcere's New IL-2 Mutant Fusion Protein Enters Phase II Trials to Fight Atopic Dermatitis Simcere Pharmaceutical’s novel IL-2 mutant protein, SIM0278, has entered Phase II clinical trials, targeting moderate-to-severe atopic dermatitis in patients.

Simcere's New IL-2 Mutant Fusion Protein Enters Phase II Trials to Fight Atopic Dermatitis #China #Hangzhou #Simcere #SIM0278 #IL-2_Mutant

1 0 0 0